Cells of hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC) not only express estrogen receptors (ER) in conjunction with or without progesterone receptors (PR) but may also overexpress HER2 on their cell surface or exhibit an amplification of its gene [1]. This evidence concerns the gene HR and breast cancer.